Detalhe da pesquisa
1.
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial.
Lancet
; 403(10432): 1141-1152, 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461841
2.
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Lancet
; 403(10432): 1153-1163, 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461843
3.
INTRAVITREAL NESVACUMAB (ANTIANGIOPOIETIN 2) PLUS AFLIBERCEPT IN DIABETIC MACULAR EDEMA: Phase 2 RUBY Randomized Trial.
Retina
; 42(6): 1111-1120, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35234673
4.
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial.
JAMA
; 328(4): 348-359, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35881122
5.
Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR study.
BMC Med Res Methodol
; 21(1): 54, 2021 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33731014
6.
Use of Composite End Points in Early and Intermediate Age-Related Macular Degeneration Clinical Trials: State-of-the-Art and Future Directions.
Ophthalmologica
; 244(5): 387-395, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33285549
7.
Intravitreal Combined Aflibercept + Anti-Platelet-Derived Growth Factor Receptor ß for Neovascular Age-Related Macular Degeneration: Results of the Phase 2 CAPELLA Trial.
Ophthalmology
; 127(2): 211-220, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31791663
8.
Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR).
Diabetes Obes Metab
; 25(3): 894-898, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331803
9.
Differing Risks of Occlusive Retinal Vasculitis with Concurrent Intraocular Inflammation Among Intravitreal Antivascular Endothelial Growth Factor Therapies.
Retina
; 41(4): 669-670, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33165295
10.
Differences in pedalling technique between road cyclists of different competitive levels.
J Sports Sci
; 34(17): 1619-26, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26703374
11.
Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing.
Adv Ther
; 41(3): 1010-1024, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38183525
12.
Heart failure management with ß-blockers: can we do better?
Curr Med Res Opin
; 40(sup1): 43-54, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38597068
13.
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.
JAMA Netw Open
; 7(4): e248383, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687481
14.
Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.
Eye (Lond)
; 38(8): 1444-1453, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38200320
15.
Vulnerable period in heart failure: a window of opportunity for the optimization of treatment - a statement by Mexican experts.
Drugs Context
; 132024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38264402
16.
Clinical practice guidelines for diagnostic and treatment of the chronic heart failure.
Arch Cardiol Mex
; 94(Supl 1): 1-74, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38648647
17.
Reported Rates of Intraocular Inflammation with Intravitreal Aflibercept Administered via Pre-Filled Syringe or from Vials in Clinical Practice Between 2012 and 2022.
Clin Ophthalmol
; 17: 385-390, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36726365
18.
Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration - a MACUSTAR study report.
Br J Ophthalmol
; 107(8): 1144-1150, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35354561
19.
Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial.
J Vitreoretin Dis
; 7(1): 8-15, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37008402
20.
Test-Retest Variability and Discriminatory Power of Measurements From Microperimetry and Dark Adaptation Assessment in People With Intermediate Age-Related Macular Degeneration - A MACUSTAR Study Report.
Transl Vis Sci Technol
; 12(7): 19, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37477933